HER2-LOW BREAST CANCER BRAIN METASTASES: INCIDENCE AND TREATMENT IMPLICATIONS

Brain metastases (BrM) are a major cause of morbidity and mortality among women with breast cancer (BC). Central nervous system (CNS)-penetrating systemic therapies for patients with HER2-negative BrM are lacking; given CNS activity of trastuzumab deruxtecan, efficacy for patients with HER2-low BrM...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehade, Rania, Nofech-Mozes, Sharon, Plotkin, Anna, Moravan, Veronika, Jerzak, Katarzyna J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337545/
http://dx.doi.org/10.1093/noajnl/vdad071.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337545/
http://dx.doi.org/10.1093/noajnl/vdad071.032

Ejemplares similares